Texas Biomed is among seven regional collaborators leveraging $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.
A key focus will be reducing health disparities among Mexican Americans, active military personnel and veterans.
William L. Henrich, MD, MACP, president of UT Health San Antonio, announced the funding from the NIH Clinical and Translational Science Awards (CTSA) Program. Henrich thanked partners including The University of Texas at Austin Dell Medical School and College of Pharmacy, The University of Texas at San Antonio and Texas Biomed for supporting the CTSA application. NIH’s National Center for Advancing Translational Sciences (NCATS) is the awarding agency.
The San Antonio Metropolitan Health District, San Antonio Military Health System, South Texas Veterans Health Care System and University Health are additional collaborators.
“This is a consortium of talented individuals at significant institutions working together to ensure that, in the future, society will be transformed through clinical advances,” Henrich said.
Read the complete story online and share. Click here.
By Will Sansom, UT Health San Antonio